Samsung Biologics, Top Search Ranking... Stock Price -1.14%
As of 1:33 PM on the 14th, Samsung Biologics is trading at 609,000 KRW, down 1.14% from the previous day. This marks a 12.99% increase compared to April 13. Samsung Biologics is known as the bio business holding company of the Samsung Group.
Today, foreigners are tentatively recorded as net sellers of 8,000 shares. Over the past five days, individual investors have net sold 234,911 shares, while foreigners and institutions have net bought 205,847 shares and 93,300 shares, respectively.
On May 13, Samsung Biologics became a market issue with the headline "New high despite prosecution investigation."
[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Living the Homebody Dream? "I Was Shocked by My Spending" How to Cut Costs to 5,000 Won for Essentials [The Principles of Benefits]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
